SEC filings :: Relmada Therapeutics, Inc. (RLMD)

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
11/13/25		Current report EX-99.1 EX-99.2			51
11/13/25		Quarterly report [Sections 13 or 15(d)] EX-31.1 EX-31.2 EX-32.1 EX-32.2			23
11/06/25		Statement of changes in beneficial ownership of securities			1
11/06/25		Statement of changes in beneficial ownership of securities			1
11/06/25		Statement of changes in beneficial ownership of securities			1
11/06/25		Statement of changes in beneficial ownership of securities			1
11/05/25		Current report EX-1.1 EX-4.1 EX-5.1 EX-5.2 EX-99.1			59
11/05/25		Prospectus [Rule 424(b)(5)]			53
11/04/25		Filing under Securities Act Rules 163/433 of free writing prospectuses			10
11/04/25		Current report EX-99.1 EX-99.2			47

rss_feed Filing RSS